Aardvark Therapeutics, Inc. Common Stock (AARD) financials · $284.4M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Aardvark Therapeutics, Inc. Common Stock (AARD) $284.4M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | N/A | $2.41M |
| Operating Income | -$62.7M | -$22.8M |
| Net Income | -$57.6M | -$20.6M |
| EPS (Diluted) | -$2.93 | -$5.15 |
| Line | FY2025 |
|---|---|
| Total Assets | $117.2M |
| Current Assets | $111.9M |
| Cash & Equivalents | $47.1M |
| Total Liabilities | $10.5M |
| Current Liabilities | $10.5M |
| Shareholders' Equity | $106.6M |
| Retained Earnings | -$115.9M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$54.2M | -$18.1M |
| CapEx | $95.0K | $109.0K |
| Investing Cash Flow | -$49.7M | -$12.0M |
| Financing Cash Flow | $89.2M | $82.0M |
| Free Cash Flow | -$54.3M | -$18.2M |
FAQ
What is AARD P/E and revenue?
Aardvark Therapeutics, Inc. Common Stock (AARD) $284.4M cap.
What is AARD revenue?
AARD income-statement cache has no revenue figure yet.
Is AARD profitable?
Aardvark Therapeutics, Inc. Common Stock last cached net income is -$57.6M (FY2025).
What are AARD total assets?
Aardvark Therapeutics, Inc. Common Stock last cached total assets are $117.2M (FY2025).
What is AARD free cash flow?
Aardvark Therapeutics, Inc. Common Stock last cached free cash flow is -$54.3M (FY2025).
Not investment advice. Cached statements, not a live tape.